How soon does tuberculosis in HIV infected patients respond to anti-tuberculous treatment? Source: Annual Congress 2010 - Tuberculosis and HIV coinfection Year: 2010
Long-term oral antibiotic treatment: why, what, when and to whom? Source: Eur Respir Monogr 2017; 75: 185-205 Year: 2017
Multi-drug-resistant tuberculosis: how is it produced, how should it be prevented, how may it be treated? Source: Annual Congress 2004 - PG11 - Multiresistant tuberculosis and atypical mycobacterial disease Year: 2004
What do they know about TB? Source: Eur Respir J 2002; 20: Suppl. 38, 163s Year: 2002
How did the tuberculosis patients reach to a tuberculosis dispensary and how long did it take? Source: Annual Congress 2011 - Challenges in tuberculosis control Year: 2011
On abandon of the tuberculosis treatment Source: Eur Respir J 2003; 22: Suppl. 45, 522s Year: 2003
Bedaquiline for the treatment of multidrug-resistant tuberculosis: another missed opportunity? Source: Eur Respir J, 49 (5) 1700738; 10.1183/13993003.00738-2017 Year: 2017
How should we treat latent tuberculosis infection? Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches Year: 2003
What do the schoolchildren know about tuberculosis? Source: Eur Respir J 2007; 30: Suppl. 51, 423s Year: 2007
What tuberculosis patients know about their diesese Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis II Year: 2008
Delay in sputum conversion of patients with treated tuberculosis; how could it be considered? Source: Eur Respir J 2007; 30: Suppl. 51, 87s Year: 2007
What do the Romany patients know about tuberculosis? Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis II Year: 2008
Is tuberculosis different in elderly patients? Source: Annual Congress 2007 - Epidemiology of tuberculosis II Year: 2007
Long term treatment out come in multi drug resistant tuberculosis Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis Year: 2010
How much do patients and doctors know about extrapulmonary tuberculosis? Source: Eur Respir J 2005; 26: Suppl. 49, 416s Year: 2005
Who is at risk for active tuberculosis? Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches Year: 2003
Antituberculosis fixed multi-dose combination and single drug therapy in active tuberculosis: What is the benefit? Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011
Is adding fluoroquinolones to regimens for treating isoniazid-resistant tuberculosis necessary? Source: Eur Respir J, 54 (4) 1901494; 10.1183/13993003.01494-2019 Year: 2019
Quantification of long term uptake and metabolism of isoniazid in patients treated for Mycobacterium tuberculosis infection Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities Year: 2009